Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants
- PMID: 27694816
- PMCID: PMC5059438
- DOI: 10.1038/ncomms12832
Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants
Abstract
Retinitis pigmentosa (RP) is a blinding disease often associated with mutations in rhodopsin, a light-sensing G protein-coupled receptor and phospholipid scramblase. Most RP-associated mutations affect rhodopsin's activity or transport to disc membranes. Intriguingly, some mutations produce apparently normal rhodopsins that nevertheless cause disease. Here we show that three such enigmatic mutations-F45L, V209M and F220C-yield fully functional visual pigments that bind the 11-cis retinal chromophore, activate the G protein transducin, traffic to the light-sensitive photoreceptor compartment and scramble phospholipids. However, tests of scramblase activity show that unlike wild-type rhodopsin that functionally reconstitutes into liposomes as dimers or multimers, F45L, V209M and F220C rhodopsins behave as monomers. This result was confirmed in pull-down experiments. Our data suggest that the photoreceptor pathology associated with expression of these enigmatic RP-associated pigments arises from their unexpected inability to dimerize via transmembrane helices 1 and 5.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






References
-
- Mendes H. F., van der Spuy J., Chapple J. P. & Cheetham M. E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11, 177–185 (2005). - PubMed
-
- Hartong D. T., Berson E. L. & Dryja T. P. Retinitis pigmentosa. Lancet (London, England) 368, 1795–1809 (2006). - PubMed
-
- Berson E. L. Retinal degenerations: planning for the future. Adv. Exp. Med. Biol. 613, 21–35 (2008). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources